NEPHROS INC

For the period ended Aug 6, 2026. Filed Aug 6, 2026.

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Aug 6, 2026 · Filed Aug 6, 2026

Use the contents to explore the available documents and sections.

NEPH$2.79-9.7%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

EX-99.1 · STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS

(In thousands, except share and per share amounts)

(Unaudited)

	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Net revenue:
Product revenues	$5,701	$4,311	$10,741	$9,017
Service, royalty and other revenues	316	108	488	279
Total net revenues	6,017	4,419	11,229	9,296
Cost of goods sold	1,991	1,624	4,210	3,347
Gross margin	4,026	2,795	7,019	5,949
Operating expenses:
Selling, general and administrative	2,418	2,201	4,939	4,455
Research and development	366	311	712	606
Depreciation and amortization	29	35	58	74
Total operating expenses	2,813	2,547	5,709	5,135
Operating income	1,213	248	1,310	814
Other (expense) income:
Interest expense	(1)	(1)	(1)	(1)
Interest income	30	31	62	44
Other income (expense), net	(32)	(32)	(21)	(53)
Total other expense:	(3)	(2)	40	(10)
Income (loss) before income taxes	1,210	246	1,350	804
Income tax expense	(13)	(9)	(13)	(9)
Net income	$1,197	$237	$1,337	$795
Net income per common share, basic	$0.11	$0.02	$0.12	$0.07
Net income per common share, diluted	$0.11	$0.02	$0.12	$0.07
Weighted average common shares outstanding, basic	10,856,541	10,600,409	10,754,248	10,600,379
Weighted average common shares outstanding, diluted	11,112,671	10,813,028	11,046,023	10,691,881

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.